Argos Therapeutics, Inc. (NASDAQ:ARGS) Consolidated Diluted EPS Stands At $-3.6559

0

For the period ended 2015-12-31, Argos Therapeutics, Inc. (NASDAQ:ARGS) delivered annual basic consolidated EPS of $-3.6559. In terms of quarterly performance, the basic consolidated EPS was $-3.6559 for the quarter ended 2015-12-31.

What about EPS from continuing operations?

Argos Therapeutics, Inc. (NASDAQ:ARGS) produced $-3.6559 in basic EPS from continuing operations for the annual period ended 2015-12-31. For the quarter, basic EPS from continuing operations was $-3.6559 for the three-month period ended 2015-12-31.

how much did parent contribute in EPS?

Argos Therapeutics, Inc. (NASDAQ:ARGS) received basic EPS boost of $-3.6559 from its parent company for the annual period ended 2015-12-31. For quarterly metrics, basic EPS contribution from the parent company was $-3.6559 for the three-month period ended 2015-12-31.

Basic net EPS

Argos Therapeutics, Inc. (NASDAQ:ARGS) posted basic net EPS of $-3.66 for the annual period ended 2015-12-31. On quarterly basis, the basic net EPS for the quarter ended 2015-12-31 was $-3.66.

Consolidated diluted EPS

Argos Therapeutics, Inc. (NASDAQ:ARGS) produced annual consolidated diluted EPS of $-3.6559 for the period ended 2015-12-31. But consolidated diluted EPS stood at $-3.6559 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS of $-3.6559 came from continuing operation for the annual period ended 2015-12-31. In terms of quarterly performance, diluted EPS from continuing operations was $-3.6559 for the quarter ended 2015-12-31.

Net diluted EPS

The company posted net diluted EPS of $-3.66 for the annual period ended 2015-12-31. Coming to the quarter, it posted net diluted EPS of $-3.66 for the three-month period ended 2015-12-31.

Diluted EPS from parent

Argos Therapeutics, Inc. (NASDAQ:ARGS) received diluted EPS boost of $-3.6559 from the parent company for the annual period ended 2015-12-31. For the quarter, diluted EPS from the parent was $-3.6559 for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Argos Therapeutics, Inc. (NASDAQ:ARGS) produced net basic EPS of $-3.66. On quarterly basis, it posted basic net EPS of $-3.66, which was for the three-month period ended 2015-12-31.

The annual average of the company’s basic shares outstanding was 20.457 for the period ended 2015-12-31. The quarterly average of basic shares outstanding was 20.457 for the quarter ended 2015-12-31.

The company had diluted shares outstanding of 20.457 for the annual period ended 2015-12-31 and 20.457 for the quarterly period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)